Dan Wolterman
CIK 1586330 · View on SEC EDGAR ↗
Insider
First SEC filing: June 4, 2026 · Latest: June 4, 2026
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 17 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 3, 2026 | HYPR | A | 52,600 | — | — | 52,600 Direct | — | Acquired | (price as of 2026-08-20) |
| May 22, 2026 | HYPR | A | 157,700 | — | — | 157,700 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 21, 2026 | GMED | A | 15,000 | — | — | 15,000 Direct | — | Acquired | (price as of 2026-08-20) |
| June 5, 2025 | HYPR | A | 81,817 | — | — | 81,817 Direct | — | Acquired | (price as of 2026-08-20) |
| May 20, 2025 | HYPR | A | 79,200 | — | — | 79,200 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 23, 2025 | GMED | A | 15,000 | — | — | 15,000 Direct | — | Acquired | (price as of 2026-08-20) |
| June 12, 2024 | HYPR | A | 79,200 | — | — | 79,200 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 26, 2024 | GMED | A | 15,000 | — | — | 15,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Sept. 1, 2023 | GMED | A | 15,000 | — | — | 15,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Sept. 1, 2023 | GMED | A | 24,025 | — | — | 24,025 Direct | — | Acquired | (price as of 2026-08-20) |
| June 9, 2023 | HYPR | A | 85,000 | — | — | 85,000 Direct | — | Acquired | (price as of 2026-08-20) |
| June 9, 2023 | HYPR | A | 112,000 | — | — | 112,000 Direct | — | Acquired | (price as of 2026-08-20) |
| June 9, 2023 | HYPR | A | 85,000 | — | — | 85,000 Direct | — | Acquired | (price as of 2026-08-20) |
| June 9, 2023 | HYPR | A | 112,000 | — | — | 112,000 Direct | — | Acquired | (price as of 2026-08-20) |
| June 9, 2022 | HYPR | A | 85,345 | — | — | 85,345 Direct | — | Acquired | (price as of 2026-08-20) |
| Dec. 23, 2021 | HYPR | A | 19,586 | — | — | 19,586 Direct | — | Acquired | (price as of 2026-08-20) |
| Dec. 23, 2021 | HYPR | A | 16,483 | — | — | 16,483 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 3, 2026 | HYPR | Stock Options (right to buy) | Class A Common Stock (52,600) | $1.49 | June 3, 2036 | 52,600 | Acquired |
| May 22, 2026 | HYPR | Stock Options (right to buy) | Class A Common Stock (157,700) | $1.49 | May 22, 2036 | 157,700 | Acquired |
| Jan. 21, 2026 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (15,000) | $94.15 | Jan. 21, 2036 | 15,000 | Acquired |
| June 5, 2025 | HYPR | Stock Options (right to buy) | Class A Common Stock (81,817) | $0.86 | June 5, 2035 | 81,817 | Acquired |
| May 20, 2025 | HYPR | Stock Options (right to buy) | Class A Common Stock (79,200) | $0.62 | May 20, 2035 | 79,200 | Acquired |
| Jan. 23, 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (15,000) | $92.42 | Jan. 23, 2035 | 15,000 | Acquired |
| June 12, 2024 | HYPR | Stock Options (right to buy) | Class A Common Stock (79,200) | $0.87 | June 12, 2034 | 79,200 | Acquired |
| Jan. 26, 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (15,000) | $53.75 | Jan. 26, 2034 | 15,000 | Acquired |
| Sept. 1, 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (15,000) | $54.23 | Sept. 1, 2033 | 15,000 | Acquired |
| June 9, 2023 | HYPR | Stock Options (right to buy) | Class A Common Stock (85,000) | $1.97 | June 9, 2033 | 85,000 | Acquired |
| June 9, 2023 | HYPR | Stock Options (right to buy) | Class A Common Stock (112,000) | $1.97 | June 9, 2033 | 112,000 | Acquired |
| June 9, 2023 | HYPR | Stock Options (right to buy) | Class A Common Stock (85,000) | $1.97 | June 9, 2023 | 85,000 | Acquired |
| June 9, 2023 | HYPR | Stock Options (right to buy) | Class A Common Stock (112,000) | $1.97 | June 9, 2033 | 112,000 | Acquired |
| June 9, 2022 | HYPR | Stock Options (right to buy) | Class A Common Stock (85,345) | $2.20 | June 9, 2032 | 85,345 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).